Neurofibromatosis Type 1: Modeling CNS Dysfunction

被引:60
|
作者
Gutmann, David H. [1 ]
Parada, Luis F. [2 ]
Silva, Alcino J. [3 ]
Ratner, Nancy [4 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Univ Calif Los Angeles, Los Angeles, CA 90095 USA
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源
JOURNAL OF NEUROSCIENCE | 2012年 / 32卷 / 41期
基金
美国国家卫生研究院;
关键词
CORPUS-CALLOSUM MORPHOLOGY; MOUSE MODEL; PROGENITOR PROLIFERATION; GLIOMA FORMATION; ABERRANT GROWTH; NF1; GENE; BRAIN; CHILDREN; PATHWAY; DIFFERENTIATION;
D O I
10.1523/JNEUROSCI.3242-12.2012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofibromatosis type 1 (NF1) is the most common monogenic disorder in which individuals manifest CNS abnormalities. Affected individuals develop glial neoplasms (optic gliomas, malignant astrocytomas) and neuronal dysfunction (learning disabilities, attention deficits). Nf1 genetically engineered mouse models have revealed the molecular and cellular underpinnings of gliomagenesis, attention deficit, and learning problems with relevance to basic neurobiology. Using NF1 as a model system, these studies have revealed critical roles for the NF1 gene in non-neoplastic cells in the tumor microenvironment, the importance of brain region heterogeneity, novel mechanisms of glial growth regulation, the neurochemical bases for attention deficit and learning abnormalities, and new insights into neural stem cell function. Here we review recent studies, presented at a symposium at the 2012 Society for Neuroscience annual meeting, that highlight unexpected cell biology insights into RAS and cAMP pathway effects on neural progenitor signaling, neuronal function, and oligodendrocyte lineage differentiation.
引用
收藏
页码:14087 / 14093
页数:7
相关论文
共 50 条
  • [31] Neurofibromatosis type 1
    Gutmann, David H.
    Ferner, Rosalie E.
    Listernick, Robert H.
    Korf, Bruce R.
    Wolters, Pamela L.
    Johnson, Kimberly J.
    NATURE REVIEWS DISEASE PRIMERS, 2017, 3
  • [32] Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1
    Aubin Moutal
    Erik T. Dustrude
    Rajesh Khanna
    Molecular Neurobiology, 2017, 54 : 3342 - 3349
  • [33] Neurofibromatosis type 1
    Mansilla-Polo, Miguel
    MEDICINA CLINICA, 2025, 164 (02): : 107 - 108
  • [35] The genetic and neuroanatomical basis of social dysfunction: Lessons from neurofibromatosis type 1
    Pride, Natalie A.
    Korgaonkar, Mayuresh S.
    Barton, Belinda
    Payne, Jonathan M.
    Vucic, Steve
    North, Kathryn N.
    HUMAN BRAIN MAPPING, 2014, 35 (05) : 2372 - 2382
  • [36] Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1
    Moutal, Aubin
    Dustrude, Erik T.
    Khanna, Rajesh
    MOLECULAR NEUROBIOLOGY, 2017, 54 (05) : 3342 - 3349
  • [37] HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1
    A Omrani
    T van der Vaart
    E Mientjes
    G M van Woerden
    M R Hojjati
    K W Li
    D H Gutmann
    C N Levelt
    A B Smit
    A J Silva
    S A Kushner
    Y Elgersma
    Molecular Psychiatry, 2015, 20 : 1311 - 1321
  • [38] Neurofibromatosis type 1
    Morse, RP
    ARCHIVES OF NEUROLOGY, 1999, 56 (03) : 364 - 365
  • [39] TYPE 1 NEUROFIBROMATOSIS
    Trifanescu, Raluca-Alexandra
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2010, 6 (01) : 127 - 127
  • [40] HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1
    Omrani, A.
    van der Vaart, T.
    Mientjes, E.
    van Woerden, G. M.
    Hojjati, M. R.
    Li, K. W.
    Gutmann, D. H.
    Levelt, C. N.
    Smit, A. B.
    Silva, A. J.
    Kushner, S. A.
    Elgersma, Y.
    MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1311 - 1321